Equities

Medical Marijuana Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MJNA:PKC

Medical Marijuana Inc

Actions
  • Price (USD)0.0002
  • Today's Change0.00 / 0.00%
  • Shares traded20.38m
  • 1 Year change-33.33%
  • Beta0.5300
Data delayed at least 15 minutes, as of Feb 13 2026 20:58 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Medical Marijuana, Inc. manufactures and distributes natural health, beauty and hemp-derived cannabidiol (CBD) products through e-commerce, direct sales, retail and wholesale distribution channels. It operates in four divisions. Medical Marijuana, Inc. division operates its Website to maintain an online presence, provide corporate, investor relations and educational information and news relating to it and the cannabis industry. HempMeds division distributes products directly in the United States and through its subsidiaries internationally primarily in Mexico and Brazil. Its product is Real Scientific Hemp Oil (RSHO). RSHO is a full spectrum, complete CBD hemp oil, which contains the natural hemp oil in the industry. RSHO is offered in three varieties: Green, Blue and Gold. Kannaway is its direct selling division, which sells its CBD products in United States, Europe and Asia. Its manufacturing facility division provides small-to-large scale Research & Development, Kitting, and others.

  • Revenue in USD (TTM)--
  • Net income in USD--
  • Incorporated2005
  • Employees--
More ▼

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
ORG Wealth Partners LLCas of 31 Dec 202515.00k0.00%
Retirement Investment Advisors, Inc.as of 31 Dec 20250.000.00%
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.